Microsporidiosis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 7: Line 7:


==Epidemiology and Demographics==
==Epidemiology and Demographics==
Microsporidiosis occur in humans worldwide, with a prevalence ranging from 0 and 50%, depending on the geographic location and demographic characteristics of the population involved. Prevalence rates tend to be highest among HIV-infected individuals with diarrhea and with a CD4+ T cells less than 100 cells/mm3 blood.<ref name="pmid16940873">{{cite journal| author=Didier ES, Weiss LM| title=Microsporidiosis: current status. | journal=Curr Opin Infect Dis | year= 2006 | volume= 19 | issue= 5 | pages= 485-92 | pmid=16940873 | doi=10.1097/01.qco.0000244055.46382.23 | pmc=3109650 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16940873  }} </ref>
===Prevalence:===
Cases of microsporidiosis have been reported in developed and developing countries and among immunosuppressed and immunocompetent individuals. Microsporidiosis has been reported in South America, Asia, and Africa where antiretroviral therapies are not readily accessible in HIV-infected patients with AIDS and it has also been seen in non-HIV infected persons such as travelers, children, the elderly and organ transplant recipients.<ref name="pmid16940873">{{cite journal| author=Didier ES, Weiss LM| title=Microsporidiosis: current status. | journal=Curr Opin Infect Dis | year= 2006 | volume= 19 | issue= 5 | pages= 485-92 | pmid=16940873 | doi=10.1097/01.qco.0000244055.46382.23 | pmc=3109650 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16940873  }} </ref>
*The overall prevalence is not accurately estimated especially in the whole population (because microsporidosis is usually investigated in immunocompromised patients with correlateing GI symptoms to microsporidosis).
*In HIV patients with diarrhea, the prevalence of microsporidosis was 39% being the most common isolated organism.
===Race===
*There is no racial predilection to the microsporidosis.
===Age===
*Patients of all age groups may develop microspordosis.
===Sex===
*Males and females are affected equally by microsporidosis.
===Geographic distribution===
*Microsporidiosis infections occur worldwide with no geographic prediliction.


==References==
==References==

Revision as of 15:30, 28 June 2017

Microsporidiosis Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Microsporidiosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory findings

X ray

CT

MRI

Other imaging studies

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Microsporidiosis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Microsporidiosis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Microsporidiosis epidemiology and demographics

CDC on Microsporidiosis epidemiology and demographics

Microsporidiosis epidemiology and demographics in the news

Blogs on Microsporidiosis epidemiology and demographics

Directions to Hospitals Treating Microsporidiosis

Risk calculators and risk factors for Microsporidiosis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Ogheneochuko Ajari, MB.BS, MS [2];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [3]

Overview

Microsporidia are being increasingly recognized as opportunistic infectious agents worldwide.

Epidemiology and Demographics

Prevalence:

  • The overall prevalence is not accurately estimated especially in the whole population (because microsporidosis is usually investigated in immunocompromised patients with correlateing GI symptoms to microsporidosis).
  • In HIV patients with diarrhea, the prevalence of microsporidosis was 39% being the most common isolated organism.

Race

  • There is no racial predilection to the microsporidosis.

Age

  • Patients of all age groups may develop microspordosis.

Sex

  • Males and females are affected equally by microsporidosis.

Geographic distribution

  • Microsporidiosis infections occur worldwide with no geographic prediliction.

References

Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Microsporidiosis_epidemiology_and_demographics&oldid=1321606"